Stora Enso Oyj (HEL:STEAV)

Intra-Cellular Therapies Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	7,157	7,657	9,864	10,503	12,809	12,383
Market Cap Growth	-26.37%	-22.38%	-6.08%	-18.01%	3.44%	19.90%
Enterprise Value	11,126	11,234	13,061	12,892	15,605	15,513
Last Close Price	9.22	9.55	12.06	12.89	14.90	14.02
PE Ratio	-	-	-	6.78	10.12	19.78
PS Ratio	0.76	0.85	1.05	0.90	1.26	1.45
PB Ratio	0.72	0.77	0.91	0.84	1.20	1.41
P/TBV Ratio	0.75	0.80	0.98	0.87	1.26	1.48
P/FCF Ratio	-	-	-	11.96	15.40	26.52
P/OCF Ratio	9.97	8.04	13.12	6.64	8.68	10.98
EV/Sales Ratio	1.19	1.24	1.39	1.10	1.54	1.81
EV/EBITDA Ratio	12.89	14.78	26.44	6.04	9.59	15.18
EV/EBIT Ratio	28.60	34.04	353.01	7.72	13.47	28.36
EV/FCF Ratio	-54.27	-	-	14.68	18.76	33.22
Debt / Equity Ratio	0.57	0.58	0.53	0.32	0.37	0.54
Debt / EBITDA Ratio	7.06	7.08	10.45	1.82	2.33	4.37
Debt / FCF Ratio	-	-	-	4.52	4.73	10.18
Asset Turnover	0.47	0.45	0.45	0.59	0.56	0.53
Inventory Turnover	3.81	3.67	3.78	4.09	4.23	3.85
Quick Ratio	0.60	0.69	1.09	0.85	0.91	0.94
Current Ratio	1.22	1.12	1.60	1.48	1.43	1.44
Return on Equity (ROE)	-1.68%	-1.76%	-3.69%	13.27%	13.04%	7.61%
Return on Assets (ROA)	1.04%	1.02%	0.11%	5.22%	3.97%	2.10%
Return on Capital (ROIC)	1.32%	1.27%	0.14%	6.71%	5.15%	2.72%
Return on Capital Employed (ROCE)	2.20%	2.10%	0.20%	9.80%	7.30%	3.80%
Earnings Yield	-1.62%	-1.78%	-3.62%	14.76%	9.88%	5.05%
FCF Yield	-2.86%	-2.10%	-2.40%	8.36%	6.49%	3.77%
Dividend Yield	2.52%	2.62%	1.66%	4.65%	3.69%	2.14%
Payout Ratio	-	-	-	28.00%	18.72%	35.62%
Buyback Yield / Dilution	3.01%	-0.01%	-0.04%	-0.03%	0.01%	0.04%
Total Shareholder Return	5.54%	2.61%	1.62%	4.62%	3.70%	2.18%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.